Plant-Derived Protease Inhibitors LC-pi (Lavatera cashmeriana) Inhibit Human Lung Cancer Cell Proliferation In Vitro

REFERENCES

• Liener IE and Kakade ML: Protease inhibitors. In: Toxic Constituents of Plant Foodstuffs, Liener IE (ed.). New York: Academic Press, 7–71, 1980.
   Google Scholar
• Mosolov VV, Grigorèva LI, and Valueva TA: Plant proteinase inhibitors as multifunctional proteins. Applied Biochemistry and Microbiology 37, 545–551, 2001.
   Web of Science ®Google Scholar
• Pandey R, Patil N, and Rao M: Proteases and Protease inhibitors: implications in antitumorigenesis and drug development. International Journal of Human Genetics 7, 67–82, 2007.
   Google Scholar
• Rahimi HR, Hasanli E, and Jamalifar H: A mini review on new pharmacological and toxicological considerations of protease inhibitors’ application in cancer prevention and biological research. Asian Journal of Cell Biology 7, 1–12, 2012.
   Google Scholar
• Skalicka-Wozniaka K, Mellioub E, Gortzic O, Glowniaka K, and Chinoub IB: Chemical constituents of Lavatera trimestris L.: antioxidant and antimicrobial activities. Z. Naturforsch 62, 797–800, 2007.
   Google Scholar
• Razavi SM, Zarrini G, Molavi G, and Ghasemi G: Bioactivity of Malva Sylvestris L., a medicinal plant from Iran. Iran J Basic Med Sci 14, 57–579, 2011.
   Google Scholar
• Hossain MS, Azad AK, Abu Sayem SM, Mostafa G, and Mozammel Hoq M: Production and partial characterization of feather-degrading keratinolytic serine protease from Bacillus licheniformis MZK-3. Journal of Boilogical Science 7, 599–606, 2007.
   Google Scholar
• Guder A and Korkmaz H: Evaluation of in-vitro antioxidant properties of hydroalcoholic solution extracts Urtica dioica L., Malva neglecta Wallr. and their mixture. Iranian Journal of Pharmaceutical Research 11, 913–923, 2012.
   PubMed Web of Science ®Google Scholar
• Farhan H, Rammal H, Hijaz A, Hamad H, Daher A, et al.: In vitro antioxidant activity of ethanolic and aqueous extracts from crude Malva parviflora l. grown in Lebanon. Asian Journal Pharm Clin Res 5, 234–238, 2012.
   Google Scholar
• Kaul MK: Medicinal Plants of Kashmir and Ladakh: Temperate and Cold Arid Himalya. New Delhi, India: Indus Publishing, 1997.
   Google Scholar
• Houghton P, Fang R, Techatanawat I, Steventon G, Hylands PJ, et al.: The sulphorhodamine (SRB) assay and other approaches to testing plant extracts and derived compounds for activities related to reputed anticancer activity. Methods 42, 377–387, 2007.
   PubMed Web of Science ®Google Scholar
• Nicolas AP, Hans MR, Jan S, Jap H, and Chris VB: Clonogenic assay of cells in vitro. Nature Protocols 5, 2315, 2006.
   Google Scholar
• Davis S, Weiss MJ, Wong JR, Lampidis TJ, and Chen LB: Mitochondrial and plasma membrane potentials cause unusual accumulation and retention of rhodamine 123 by human breast adenocarcinoma-derived MCF-7 cells. J Biol Chem 260, 13844–13850, 1985.
   PubMed Web of Science ®Google Scholar
• Kubota Y, Kubota K, and Tani S: DNA binding properties of Dapi (4’, 6-diamino-2-phenylindole) analogs having an imidazoline ring or a tetrahydropylindole ring: groove-binding and intercalation. Nucleic Acids Symposium 44, 53–54, 2000.
   PubMedGoogle Scholar
• Frankfurt OS and Krishnan A: Apoptosis based drug screening and detection of selective cytotoxicity to cancer cells. Anti Cancer Drugs 14, 555–561, 2003.
   PubMed Web of Science ®Google Scholar
• Qian W, Rajiv D, and Alan W: Altered CXCR3 Isoform expression regulates prostate cancer cell migration and invasion. Molecular Cancer 11, 3, 2012.
   PubMed Web of Science ®Google Scholar
• Yang P, Taniguchi K, Deschampes C, Bass E, Meyer R, et al.: Neutrophil elastase gene in lung cancer development: evidence from molecular genetics and clinical epidemiology. Nature Genetics 27, 97, 2001.
   Google Scholar
• Taniguchi K, Yang P, Jett J, Bass E, Meyer R, et al.: Polymorphisms in the promoter region of the neutrophil elastase gene are associated with lung cancer development. Clinical Cancer Research 8, 1115–1120, 2002.
   PubMed Web of Science ®Google Scholar
• Sun Z and Yang P: Role of imbalance between neutrophil elastase and 1-antitrypsin in cancer development and progression. Lancet Oncol 5, 182–190, 2004.
   PubMed Web of Science ®Google Scholar
• Park JY, Chen L, Lee J, Sellers T, and Tockman MS: Polymorphisms in the promoter region of neutrophil elastase gene and lung cancer risk. Lung Cancer 48, 315–321, 2005.
   PubMed Web of Science ®Google Scholar
• Terada T, Ohta T, Minato H, and Nakanuma Y: Expression of pancreatic trypsinogen/trypsin and cathepsin B in human cholangiocarcinomas and heptocellular carcinomas. Hum Pathol 26, 746–752, 1995.
   PubMed Web of Science ®Google Scholar
• Ohta T, Terada T, Nagakawa T, Tajima H, Itoh H, et al.: Pancreatic trypsinogen and Cathepsin B in human pancreatic carcinomas and associated metastatic lesions. Bri J Cancer 69, 52–156, 1994.
   Web of Science ®Google Scholar
• Kawano N, Osawa H, Ito T, Nagashima Y, Hirahara F, et al.: Expression of gelatinase A, tissue inhibitor of metalloproteinase-2, matrilysin and trypsin(ogen) in lung neoplasm: an immunohistochemical study. Hum Pathol 28, 613–622, 1997.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Ikv S, Adachi Y, Imsumran A, Taniguchi H, et al.: Association of trypsin expression with tumor progression and matrilysin expression in human colorectal cancer. J Pathol 199, 176–184, 2003.
   PubMed Web of Science ®Google Scholar
• Diederichs S, Bulk E, Steffen B, Ji P, Tickenbrock L, et al.: S100 family members and trypsinogen are predictors of distant metastasis and survival in early-stage non-small cell lung cancer. Cancer Research 64, 5564–5569, 2004.
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Iku S, Itoh F, Tang X, Hosokawa M, et al.: Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma. Cancer 91, 1324–1331, 2001.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Saksela O, Osman S, Huhtala ML, and Stenman UH: Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumour-associated trypsinogen. International Journal of Cancer Research 47, 592–596, 1991.
   PubMed Web of Science ®Google Scholar
• Puja A, Sorsa T, Tervahartiala T, Koivunen E, Haglund C, et al.: The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation. British Journal of Cancer 84, 1363–1371, 2011.
   Google Scholar
• Nyberg P, Moilanen M, Paju A, Sarin A, Stenman UH, et al.: MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J Dent Res 81, 831—835, 2002.
   PubMed Web of Science ®Google Scholar
• Nyberg P, Ylipalosaari M, Sorsa T, and Sal T: Trypsin and their role in carcinoma growth. Exp Cell Res 312, 1219–1228, 2006.
   PubMed Web of Science ®Google Scholar
• Weigelt B, Peterse JL, and van't Veer LJ: Breast cancer metastasis: markers and models. Nature Review Cancer 5, 591–602, 2005.
   PubMed Web of Science ®Google Scholar
• Pillay V, Dass CR, and Choong PFM: The urokinase plasminogen activator receptor as a gene therapy target for cancer. Trends in Biotechnology 25, 33–39, 2007.
   PubMed Web of Science ®Google Scholar
• Prezas P, Arlt MJ, Viktorov P, Soosaipillai A, Holzscheiter L, et al.: Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells. Biol Chem 387, 807–811, 2006.
   PubMed Web of Science ®Google Scholar
• Kim JT, Song EY, Chung KS, Kang MA, Kim JW, et al.: Up-regulation and clinical significance of serine protease kallikrein 6 in colon cancer. Cancer 117, 1–12, 2011.
   PubMed Web of Science ®Google Scholar
• Mageea PJ, Owusu-Apentena R, McCannb MJ, Gilla CI, and Rowland IR: Chickpea (Cicer arietinum) and other plant-derived protease inhibitor concentrates inhibit breast and prostate cancer cell proliferation in vitro. Nutrition and Cancer 64, 741–748, 2012.
   PubMed Web of Science ®Google Scholar
• Birk Y: Plant Protease Inhibitors. Berlin, Germany: Springer, 2003.
   Google Scholar
• Kobayashi H, Suzuki M, Kanayama N, and Terao T: A soybean Kunitz trypsin inhibitor suppresses ovarian cancer cell invasion by blocking urokinase upregulation. Clinical and Experimental Metastasis 21, 159–166, 2004.
   PubMed Web of Science ®Google Scholar
• Wong JH and Ng TB: Isolation and characterization of a glucose/mannose/rhamnose-specific lectin from the knife bean Canavalia gladiate. Archives of Biochemistry and Bio-Physics 439, 91–98, 2005.
   PubMed Web of Science ®Google Scholar
• Sun J, Wang H, and Ng TB: Trypsin isoinhibitors with antiproliferative activity toward leukemia cells from Phaseolus vulgaris cv “white cloud bean.” Journal of Biomedicine and Biotechnology, 2010, 8, 2010.
   Google Scholar
• Ye XJ and Ng TB: Antitumor and HIV-1 reverse transcriptase inhibitory activities of a hemagglutinin and a protease inhibitor from mini-black soybean. Evidence-Based Complementary and Alternative Medicine, 2011, 12, 2011.
   Web of Science ®Google Scholar
• Cheung AHK and Tzi BN: Isolation and characterization of a trypsin-chymotrypsin inhibitor from the seeds of green lentil (Lens culinaris). Protein and Peptide Letters 14, 859–864, 2007.
   PubMed Web of Science ®Google Scholar
• Cheung AHK, Wong JH, and Ng TB: Trypsin- chymotrypsin inhibitors from Vigna mungo seeds. Protein and Peptide Letters 16, 277–284, 2009.
   PubMed Web of Science ®Google Scholar
• Zhang X, Wang H, and Tzi BN: Isolation and characterization of a novel trypsin inhibitor from fresh lily bulbs. Planta Medica 74, 546–550, 2008.
   PubMed Web of Science ®Google Scholar
• Lanza A, Tava A, Catalano M, Ragona L, Singuaroli I, et al.: Effects of the Medicago scutellata trypsin inhibitor (MsTI) on cisplatin-induced cytotoxicity in human breast and cervical cancer cells. Anticancer Research 24, 227–234, 2004.
   PubMed Web of Science ®Google Scholar
• Clemente A, Marín-Manzano MC, Jiménez E, Carmen Arques M, and Domoney C: The anti-proliferative effect of TI1B, a major Bowman-Birk isoinhibitor from pea (Pisum sativum L.), on HT29 colon cancer cells is mediated through protease inhibition. Br J Nutr 108, 135–144, 2012.
   PubMed Web of Science ®Google Scholar
• Savill J and Fadok V: Corpse clearance defines the meaning of cell death. Nature 407, 784–788, 2000.
   PubMed Web of Science ®Google Scholar
• Earnshaw WC, Martins LM, and Kaufmann SH: Mammalian caspases: structure, activation, substrates, and functions during apoptosis. Annu Rev Biochem 68, 383–424, 1999.
   PubMed Web of Science ®Google Scholar
• Krammer PH: CD95's deadly mission in the immune system. Nature 407, 789–795, 2000.
   PubMed Web of Science ®Google Scholar
• Puthalakath H and Strasser A: Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ 9, 505–512, 2002.
   PubMed Web of Science ®Google Scholar
• Leist M and Jaattela M: Four deaths and a funeral: from caspases to alternative mechanisms. Nature Rev Mol Cell Biology 2, 589–598, 2001.
   PubMed Web of Science ®Google Scholar
• Waterhouse NJ, Goldstein von Ahsen JCO, Schuler M, Newmeyer DD, and Green DR: Cytochrome c maintains mitochondrial transmembrane potential and ATP generation after outer mitochondrial membrane permeabilization during the apoptotic process. J Cell Biol 153, 319–328, 2001.
   PubMed Web of Science ®Google Scholar
• Egger L, Schneider J, Rheme C, Tapernoux M, Hacki J, et al.: Serine proteasesmediate apoptosis-like cell death and phagocytosis under caspase-inhibiting conditions. Cell Death and Differentiation 10, 1188–1203, 2003.
   PubMed Web of Science ®Google Scholar
• Frydrych I and Mlejnek P:. Serine protease inhibitors N-alpha-tosyl-L-lysinyl chloro-methylketone (TLCK) and N-tosyl-L-phenylalaninyl-chloromethylketone (TPCK) are potent inhibitors of activated caspase proteases. Journal of Cell Biochemistry 103, 1646–1656, 2008.
   PubMed Web of Science ®Google Scholar
• Jitkaew S, Trebinska A, Grzybowska E, Carlsson G, Nordstro A, et al.: Nα-tosyl-l-phenylalanine chloromethyl ketone induces caspase-dependent apoptosis in transformed human B cell lines with transcriptional down-regulation of anti-apoptotic HS1-associated protein X-1. The Journal of Biological Chemistry 284, 27827–27837, 2009.
   PubMed Web of Science ®Google Scholar
• Park SS and Ohba AH: Suppressive activity of protease inhibitors from buckwheat seeds against human T-acute lymphoblastic leukemia cell lines. Applied Biochemistry and Biotechnology 117, 64–74, 2004.
   Web of Science ®Google Scholar
• Yavelow J, Collins M, Birk Y, Troll W, and Kennedy AR: Proc Natl Acad Science 82, 5395–5399, 1985.
   PubMed Web of Science ®Google Scholar
• Ferreira CG, Epping M, Kruyt FA, and Giaccone G: Apoptosis: target of cancer therapy. Clin Cancer Res 8, 2024–2034, 2002.
   PubMed Web of Science ®Google Scholar
• Gupta SC, Kim JH, Prasad S, and Aggarwal BB: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29, 405–434 2010.
   PubMed Web of Science ®Google Scholar
• Clemente A, Moreno FJ, Marín-Manzano MC, Jiménez E, and Domoney C: The cytotoxic effect of Bowman-Birk isoinhibitors, IBB1 and IBBD2, from soybean (Glycine max) on HT29 human colorectal cancer cells is related to their intrinsic ability to inhibit serine proteases. Mol Nutr Food Res 54, 396–405, 2010.
   PubMed Web of Science ®Google Scholar
• Sun L, Niu L, Zhu X, Hao J, Wang P, et al.: Antitumour effects of a protease inhibitor, nelfinavir, in hepatocellular carcinoma cancer cells. J Chemother 24, 161–166, 2012.
   PubMed Web of Science ®Google Scholar
• Repesh LA: A new in vitro assay for quantiating tumour cell invasion. Invasion Metastasis 9, 192–208, 1998.
   Google Scholar
• Birkedai-Hansen H: Proteolytic remodeling of extracellular matrix. Current Opinion Cell Biology 7, 728–735, 1995.
   PubMed Web of Science ®Google Scholar
• Gomez DE, Skilton G, Alonso DF, and Kazanietz M: The role of protein kinase C and novel phorbol ester receptors in tumor cell invasion and metastasis (Review). Oncol. Rep 6, 1363–1433, 1999.
   PubMed Web of Science ®Google Scholar
• Koivunen E, Itkonen O, Halila H, and Stenman UH: Cyst fluid of ovarian cancer patients contains high concentration of trypsinogen-2. Cancer Research 50, 2375–2378, 1990.
   PubMed Web of Science ®Google Scholar
• Williams SJ, Gotley DC, and Antalis TM: Human trypsinogen in colorectal cancer. International Journal of Cancer 93, 67–73, 2001.
   PubMed Web of Science ®Google Scholar
• Yamashita K, Mimori K, Inoue H, Mori M, and Sidransky D: A tumor-suppressive role for trypsin in human cancer progression. Cancer Research 63, 6575–6578, 2003.
   PubMed Web of Science ®Google Scholar
• Vilen ST, Nyberg P, Hukkanen M, Sutinen M, Ylipalosaari M, et al.: Intracellular co-localization of trypsin-2 and matrix metalloprotease-9: possible proteolytic cascade of trypsin-2, MMP-9 and enterokinase in carcinoma. Exp Cell Res 314, 914–926, 2008.
   PubMed Web of Science ®Google Scholar
• Suen JY, Barry GD, Lohman RJ, Halili MA, Cotterell AJ, et al.: Modulating human proteinase activated receptor 2 with a novel antagonist (GB88) and agonist (GB110). British J Pharmacol 165, 413–423, 2012.
   Web of Science ®Google Scholar
• Vilen ST, Suojanen J, Salas F, Risteli J, Ylipalosaari M, et al.: Trypsin-2 enhances the invasion of tongue carcinoma via regulation of tight junction and MMPs. Cancer Invest 30, 583–592, 2012.
   PubMed Web of Science ®Google Scholar
• Shi X, Gangadharan B, Brass LF, Ruf W, and Mueller BM: Protease-activated receptors (PAR1 and PAR2) contribute to tumor cell motility and metastasis. Mol Cancer Res 2, 395–402, 2004.
   PubMed Web of Science ®Google Scholar
• Jahan I, Fujimoto J, Mahfuzul S, Sato E, and Tamaya T: Role of protease activated receptor-2 in lymph node metastasis of uterine cervical cancers. BMC Cancer 8, 301, 2008.
   PubMed Web of Science ®Google Scholar
• Ramachandran R, Noorbakhsh F, Defea K, and Hollenberg MD: Targeting proteinase-activated receptors: therapeutic potential and challenges. Nat Rev Drug Discov 11, 69–86, 2012.
   PubMed Web of Science ®Google Scholar
• Han CL, Cheng JS, Chan EC, Wu CP, Yu KH, et al.: An informatics-assisted lable-free approach for personalized tissue membrane proteomics: case study on colorectal cancer. Molecular Cell Proteomics 10, M110.003087, 2013.
   Web of Science ®Google Scholar
• Barrett AJ: Leukocyte elastase. Methods Enzymol 80, 581–588, 1981.
   PubMed Web of Science ®Google Scholar
• Moroy G, Alix AJ, Sapi J, Hornebeck W, and Bourguet E: Neutrophil elastase as a target in lung cancer. Anticancer Agents Med Chem 12, c565–c579, 2012.
   PubMed Web of Science ®Google Scholar
• Morjena M, Kallech-ziria O, Bazaaa A, Othmana H, Mabroukb K, et al.: PIVL, a new serine protease inhibitor from Macrovipera lebetina transmediterranea venom, impairs motility of human glioblastoma cells. Matrix Biology 32, 52–62, 2013.
   PubMed Web of Science ®Google Scholar